Voloridge Investment Management
CVAC

Voloridge Investment Management’s CureVac CVAC Stock Holding History

Voloridge Investment Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-43,842
Closed -$345K – 1475
2022
Q3 		$345K Buy
+43,842
New +$511K ﹤0.01% 1313
2022
Q2 		– Sell
-237,195
Closed -$4.65M – 1462
2022
Q1 		$4.65M Buy
237,195
+3,920
+2% +$78.3K 0.03% 659
2021
Q4 		$8M Sell
233,275
-10,701
-4% -$431K 0.04% 534
2021
Q3 		$13.3M Buy
243,976
+107,363
+79% +$6.47M 0.09% 327
2021
Q2 		$10M Buy
136,613
+6,930
+5% +$693K 0.07% 411
2021
Q1 		$11.9M Buy
+129,683
New +$12.6M 0.09% 303

Other funds holding CVAC

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Voloridge Investment Management's CVAC Position: Q4 2022 in Review

Voloridge Investment Management sold out of CureVac (CVAC) in Q4 2022, closing a stake of 43,842 shares — an estimated $345K sold.

Voloridge Investment Management first reported a position in CVAC in Q1 2021 and held it in 6 quarters. The position peaked at $13.3M in Q3 2021. 83 funds tracked by Wall St. Rank hold CVAC as of Q4 2022.

  • Voloridge Investment Management reported no remaining CureVac position as of Q4 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 43,842 CureVac shares in Q4 2022, an estimated $345K.
  • Voloridge Investment Management first reported a position in CureVac in Q1 2021 and held it in 6 quarters.
  • Voloridge Investment Management's CureVac position peaked at $13.3M in Q3 2021.
  • 83 funds tracked by Wall St. Rank held CureVac as of Q4 2022.

Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.